Title : Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability.

Pub. Date : 1999 May

PMID : 10414398






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CC16 concentration (mean+/-sD in microg x L(-1)), measured by a sensitive latex immunoassay, was significantly reduced in BALF of all treated groups (IPO 380+/-100; MMT 730+/-200; ANTU 1,070+/-200; controls 1,700+/-470). 4-ipomeanol methylthioadenosine phosphorylase Rattus norvegicus
2 CC16 concentration (mean+/-sD in microg x L(-1)), measured by a sensitive latex immunoassay, was significantly reduced in BALF of all treated groups (IPO 380+/-100; MMT 730+/-200; ANTU 1,070+/-200; controls 1,700+/-470). 2-methylcyclopentadienyl manganese tricarbonyl methylthioadenosine phosphorylase Rattus norvegicus
3 CC16 concentration (mean+/-sD in microg x L(-1)), measured by a sensitive latex immunoassay, was significantly reduced in BALF of all treated groups (IPO 380+/-100; MMT 730+/-200; ANTU 1,070+/-200; controls 1,700+/-470). alpha-naphthyl thiourea methylthioadenosine phosphorylase Rattus norvegicus
4 In serum, by contrast, CC16 was significantly increased in all treated groups (IPO 31+/-7; MMT 22+/-12; ANTU 52+/-24; controls 15+/-6). 4-ipomeanol methylthioadenosine phosphorylase Rattus norvegicus
5 In serum, by contrast, CC16 was significantly increased in all treated groups (IPO 31+/-7; MMT 22+/-12; ANTU 52+/-24; controls 15+/-6). 2-methylcyclopentadienyl manganese tricarbonyl methylthioadenosine phosphorylase Rattus norvegicus